Entod Pharmaceuticals inaugurated its state-of-the-art Research & Development (R&D) Centre in Navi Mumbai on January 28th. The Department of Scientific and Industrial Research (DSIR) approved research laboratory is equipped with the latest molecular and formulation research tools, microbiology testing facilities, sterile batch production capacity, and high-end Quality Assurance/Quality Control analytical equipments.

The new R&D Centre underscores Entod's commitment to pioneering pharmaceutical innovation, contributing to India's aspirations to become a value-driven innovation hub in the specialty pharmaceutical space.

The facility will focus on developing next-generation molecules using generative artificial intelligence (AI) platforms, particularly in the ophthalmic, ENT, paediatrics and skincare segments. Some of these groundbreaking molecules are expected to be indigenous to India, marking a significant stride towards global pharmaceutical leadership.

The inaugural event was graced by esteemed guests including the renowned ophthalmologist and philanthropist Dr Kulin Kothari, renowned ENT surgeon and otorhinolaryngologist Dr Ashesh Bhumkar, renowned paediatrician Dr Suhash Prabhu, renowned dermatologist and cosmetologist Dr Kiran V Godse and ex-chemistry teacher of the highest reputed Jamnabai Narsee School Shallette Luis.